159 related articles for article (PubMed ID: 14628595)
1. [Tumor infiltrating dendritic cells and Mucin1 gene expression in benign prostatic hyperplasia and prostate cancer].
Xiang ST; Zhou SW; Guan W; Wang QZ; Zhang B; Liu JH; Ye ZQ
Zhonghua Nan Ke Xue; 2003 Oct; 9(7):497-500. PubMed ID: 14628595
[TBL] [Abstract][Full Text] [Related]
2. [Expression of MUC1 and distribution of tumor-infiltrating dentritic cells in human bladder transitional cell carcinoma].
Xiang ST; Zhou SW; Guan W; Liu JH; Ye ZQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1114-8. PubMed ID: 16174576
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.
Singh AP; Chauhan SC; Bafna S; Johansson SL; Smith LM; Moniaux N; Lin MF; Batra SK
Prostate; 2006 Mar; 66(4):421-9. PubMed ID: 16302265
[TBL] [Abstract][Full Text] [Related]
4. Expression of sialylated MUC1 in prostate cancer: relationship to clinical stage and prognosis.
Arai T; Fujita K; Fujime M; Irimura T
Int J Urol; 2005 Jul; 12(7):654-61. PubMed ID: 16045558
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues].
Zhen B; Shen Y; Zhang YM; Zhu CH; Liu ZL
Zhonghua Nan Ke Xue; 2006 May; 12(5):416-20. PubMed ID: 16755871
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of clusterin in normal prostate, benign prostate hyperplasia and prostate cancer].
Zhou LQ; Yang XZ; Zeng L; Liang LL; Yang XY; Ren L; Chung L; Zhang ZW; Na YQ; Gu FL; Guo YL
Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):93-5. PubMed ID: 12783666
[TBL] [Abstract][Full Text] [Related]
8. CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator?
Ang J; Lijovic M; Ashman LK; Kan K; Frauman AG
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1717-21. PubMed ID: 15533898
[TBL] [Abstract][Full Text] [Related]
9. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
Vallbo C; Wang W; Damber JE
BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
[TBL] [Abstract][Full Text] [Related]
10. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells.
Kramer G; Steiner GE; Gröbl M; Hrachowitz K; Reithmayr F; Paucz L; Newman M; Madersbacher S; Gruber D; Susani M; Marberger M
Prostate; 2004 Feb; 58(2):109-20. PubMed ID: 14716736
[TBL] [Abstract][Full Text] [Related]
11. Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation.
Chaux P; Hammann A; Martin F; Martin M
Eur J Immunol; 1993 Oct; 23(10):2517-25. PubMed ID: 8405052
[TBL] [Abstract][Full Text] [Related]
12. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
Hussein MR; Al-Assiri M; Musalam AO
Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
[TBL] [Abstract][Full Text] [Related]
14. [Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance].
Jin TX; Li XG; Wu WY; Piao DM; Feng JY; Sang J
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):207-10. PubMed ID: 16597032
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.
Hudolin T; Juretic A; Spagnoli GC; Pasini J; Bandic D; Heberer M; Kosicek M; Cacic M
Prostate; 2006 Jan; 66(1):13-8. PubMed ID: 16114059
[TBL] [Abstract][Full Text] [Related]
16. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
Luo J; Duggan DJ; Chen Y; Sauvageot J; Ewing CM; Bittner ML; Trent JM; Isaacs WB
Cancer Res; 2001 Jun; 61(12):4683-8. PubMed ID: 11406537
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters.
Ebelt K; Babaryka G; Frankenberger B; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Eur J Cancer; 2009 Jun; 45(9):1664-72. PubMed ID: 19318244
[TBL] [Abstract][Full Text] [Related]
18. Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules.
Burke PA; Gregg JP; Bakhtiar B; Beckett LA; Denardo GL; Albrecht H; De Vere White RW; De Nardo SJ
Int J Oncol; 2006 Jul; 29(1):49-55. PubMed ID: 16773184
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma].
Lai JS; Xia Q; Zhang XB; Zhao GP; Xu SL; Zheng DS
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):476-8. PubMed ID: 15555337
[TBL] [Abstract][Full Text] [Related]
20. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
